Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 13, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that it has agreed to donate Cardiac Rhythm Management (CRM) devices, including...
-
May 12, 2009
Company's new lead system reduces implant size of the world's smallest and thinnest high-energy devices NATICK, Mass., May 12 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today...
-
May 11, 2009
Boston Scientific Corporation today welcomed the publication of an article...
-
May 11, 2009
Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements at the 30th Annual Scientific...
-
May 6, 2009
Data from landmark trial provide important insight for physicians in treating heart attack patients NATICK, Mass., May 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today welcomed the...
-
May 5, 2009
Boston Scientific Corporation is scheduled to participate in the upcoming Bank of America and Merrill Lynch Health Care Conference. Jim Tobin,...
-
Apr 20, 2009
Boston Scientific Corporation today announced financial results for the first quarter ended March 31, 2009, as well as guidance for net sales and...
-
Apr 15, 2009
Boston Scientific today announced special items that will reduce its GAAP earnings for the first quarter. The Company plans to release its first...
-
Apr 6, 2009
Boston Scientific Corporation will webcast its conference call discussing financial results for the first quarter ended March 31, 2009 on Tuesday,...
-
Mar 31, 2009
Boston Scientific Corporation announced today that the Court of Appeals for the Federal Circuit issued a decision in the Company's stent...
-
Mar 31, 2009
Boston Scientific Corporation today welcomed passage of the National Pain Care Policy Act of 2009 by the U.S. House of Representatives. The...
-
Mar 29, 2009Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent PlatformsThree-year results and two-year pooled analysis presented at ACC demonstrate continued positive outcomes for both PROMUS® and TAXUS® Stents
Boston Scientific Corporation today welcomed three-year results from the SPIRIT II Clinical Trial and a pooled meta-analysis of...
-
Mar 28, 2009
Boston Scientific Corporation today announced results from an analysis of economic and quality of life outcomes, based on...
-
Mar 26, 2009
Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements at the 58th Annual Scientific...
-
Mar 25, 2009
Boston Scientific Corporation today announced that Standard and Poor's Ratings Services has raised the Company's rating outlook to positive from...
-
Mar 19, 2009
Boston Scientific Corporation today announced the launch of its iCross™ Coronary Imaging Catheter, a product designed to improve the...
-
Mar 12, 2009
Boston Scientific Corporation today announced that Moody's Investors Service has raised the Company's rating outlook to stable from negative. In...
-
Mar 10, 2009
Boston Scientific Corporation is scheduled to participate in the upcoming Cowen and Company 29th Annual Health Care Conference. Jim Tobin, Chief...
-
Mar 4, 2009
Boston Scientific Corporation today welcomed approval by the U.S. House of Representative's Energy and Commerce Committee of the National Pain Care...
-
Mar 3, 2009
Boston Scientific Corporation today announced the launch of its TAXUS®...
-
Mar 2, 2009
Boston Scientific Corporation today announced that the Company's Board of Directors has elected John E. Sununu...
-
Feb 26, 2009
Boston Scientific Corporation today announced updated financial results for the fourth quarter ended December 31, 2008. Subsequent to the release...
-
Feb 18, 2009
Data show comparable safety for complex patients treated with TAXUS® Express2™ Stents and bypass surgery NATICK, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today...
-
Feb 5, 2009
Journal of American College of Cardiology publishes positive ATLAS clinical data NATICK, Mass., Feb. 5 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it has submitted...
-
Feb 3, 2009
PLATINUM clinical program to evaluate PROMUS™ Element™ Platinum Chromium Stent NATICK, Mass., Feb. 3 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced the beginning of...